Carregant...

Biomarkers in Exploring the Frontiers of Diagnosis, Prognosis, and Therapy of Barrett’s Esophagus

Barrett’s esophagus (BE) is the principal risk factor for esophageal adenocarcinoma. BE patients currently undergo periodic endoscopic surveillance with tissue sampling and histopathologic assessment for dysplasia. They frequently are prescribed proton pump inhibitors to pharmacologically suppress g...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yachimski, Patrick, Peek, Richard M.
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3174469/
https://ncbi.nlm.nih.gov/pubmed/21636544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-11-0204
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!